The stock of Nobilis Health Corp (USA) (NYSEMKT:HLTH) is a huge mover today! The stock increased 10.74% or $0.32 during the last trading session, hitting $3.35. About 1.63 million shares traded hands or 714.47% up from the average. Nobilis Health Corp (USA) (NYSEMKT:HLTH) has risen 2.04% since March 28, 2016 and is uptrending. It has underperformed by 2.67% the S&P500.
The move comes after 7 months positive chart setup for the $230.35M company. It was reported on Oct, 28 by Barchart.com. We have $8.81 PT which if reached, will make NYSEMKT:HLTH worth $375.47 million more.
Analysts await Nobilis Health Corp (USA) (NYSEMKT:HLTH) to report earnings on January, 10. They expect $0.08 EPS, up 60.00% or $0.03 from last year’s $0.05 per share. HLTH’s profit will be $5.50M for 10.47 P/E if the $0.08 EPS becomes a reality. After $0.06 actual EPS reported by Nobilis Health Corp (USA) for the previous quarter, Wall Street now forecasts 33.33% EPS growth.
According to Zacks Investment Research, “Nobilis Health Corp. own and manage ambulatory and acute care facilities for healthcare services. In addition, it owns and manages ambulatory surgery centers, acute care hospital, imaging centers and urgent care clinic. The company operates primarily in Houston, Dallas and Scottsdale, Arizona. Nobilis Health Corp. is headquartered in Houston, Texas.”
More important recent Nobilis Health Corp (USA) (NYSEMKT:HLTH) news were published by: Marketwired.com which released: “Nobilis Health Corp. Announces Completion of Acquisition of Arizona Vascular …” on October 28, 2016, also Bidnessetc.com published article titled: “Here’s Why Nobilis Health Corp (USA) Stock Is down Today”, Stockhouse.com published: “IIROC Trade Halt – Nobilis Health Corp.” on October 28, 2016. More interesting news about Nobilis Health Corp (USA) (NYSEMKT:HLTH) was released by: Marketwired.com and their article: “Nobilis Health Corp. Launches Bundled-Payment and Health Technology Initiative …” with publication date: May 02, 2016.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.